Harry Quon, M.D., M.S.

Headshot of Harry Quon
  • Co-Director, Johns Hopkins Head and Neck Cancer Multidisciplinary Clinic
  • Associate Professor of Radiation Oncology and Molecular Radiation Sciences
Male

Expertise

Head and Neck Cancers, Radiation Oncology

Request an Appointment

Insurance Information

Main Phone

Outside of Maryland & Washington D.C.

Request Appointment

International Patients

Request Appointment

Locations

Johns Hopkins Sidney Kimmel Comprehensive Cancer Center

Appointment Phone: 410-502-8000
401 N. Broadway
Baltimore, MD 21231 map

Background

Dr. Harry Quon is an associate professor of radiation oncology and molecular radiation sciences at the Johns Hopkins University School of Medicine. He also holds appointments in oncology and in otolaryngology - head and neck surgery. His area of clinical expertise is radiation treatment for head and neck cancers. 

He serves as the co-director of the Johns Hopkins Head and Neck Cancer Multidisciplinary Clinic.

Dr. Quon received his M.D. from the University of Toronto Institute of Medical Science. He completed his residency at the Princess Margaret Hospital in Ontario and performed a fellowship in radiation oncology at the Princess Margaret Hospital and the Beth Israel Medical Center.

Make A Gift

...read more

Titles

  • Co-Director, Johns Hopkins Head and Neck Cancer Multidisciplinary Clinic
  • Associate Professor of Radiation Oncology and Molecular Radiation Sciences
  • Associate Professor of Oncology
  • Associate Professor of Otolaryngology - Head and Neck Surgery

Departments / Divisions

Centers & Institutes

Education

Degrees

  • MD; University of Toronto - Temerty Faculty of Medicine (1993)

Residencies

  • Radiation Oncology; Princess Margaret Hospital (1998)

Fellowships

  • Radiation Oncology; Beth Israel Medical Center (2000)
  • Radiation Oncology; Princess Margaret Hospital (1999)

Board Certifications

  • American Board of Radiology (Radiation Oncology) (1999)

Research & Publications

Research Summary

Dr. Quon’s research focuses on reducing treatment toxicity. He is leading research into different strategies that are de-intensifying therapy in oropharynx cancers that are associated with the human papillomavirus (HPV).

Clinical Trials

A Phase II Study of Treatment De-Intensification in Favorable Squamous Cell Carcinoma of the Oropharynx

Patient Ratings & Comments

The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

Is this you? Edit Profile
back to top button